Pfizer Inc. (PFE) filed a Form 8K - Regulation FD Disclosure -
with the U.S Securities and Exchange Commission on May 27,
2014.
On May 26, 2014, Pfizer Inc. issued an announcement (the
"Announcement") pursuant to Rule 2.8 of the U.K. City Code on
Takeovers and Mergers announcing that it does not intend to make an
offer for AstraZeneca plc. A copy of the Announcement is attached
hereto as Exhibit 99.1 and is incorporated by reference into this
Item 7.01.
Pursuant to General Instruction B.2. to Form 8-K, the
information set forth in this Item 7.01 (except insofar as such
information is also set forth under Item 8.01 below) shall not be
deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section.
The full text of this SEC filing can be retrieved at:
http://www.sec.gov/Archives/edgar/data/78003/000119312514212123/d732803d8k.htm
Any exhibits and associated documents for this SEC filing can be
retrieved at:
http://www.sec.gov/Archives/edgar/data/78003/000119312514212123/0001193125-14-212123-index.htm
Public companies must file a Form 8-K, or current report, with
the SEC generally within four days of any event that could
materially affect a company's financial position or the value of
its shares.
Access Investor Kit for Pfizer Inc.
Visit
http://www.companyspotlight.com/partner?cp_code=A591&isin=US7170811035
Subscribe to WSJ: http://online.wsj.com?mod=djnwires